Clinical Trial Update: Salicylic Augmentation in Depression [Phase 2]

View source ↗

Summary

Phase 2 trial investigating salicylic augmentation in depression was terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Salicylic augmentation (salicylic augmentation)

Snippet

Sponsor: Jessica Harder | Conditions: Depression, Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2024-01-31